ESR1 and gastric cancer: When TAM was used at concentrations (1 μM) that do not affect cell proliferation of ERα-negative MK-1 cells (Supplementary Figure 2B), TAM did not significantly suppress both E2-induced Hh activation and E2-induced cell proliferation of ERα-positive gastric cancer cells (Supplementary Figure 2A).